Russell Frank Company’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Russell Frank Company’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$67K	Buy	+11,800	New	+$82.4K	﹤0.01%	2832
2015 Q4	–	Sell	-118,443	Closed	-$2.19M	–	3157
2015 Q3	$2.19M	Buy	118,443 +76,497	+182%	+$1.48M	﹤0.01%	1793
2015 Q2	$816K	Buy	41,946 +6,505	+18%	+$115K	﹤0.01%	2404
2015 Q1	$623K	Buy	+35,441	New	+$595K	﹤0.01%	2338
2013 Q4	–	Sell	-9,403	Closed	-$156K	–	3512
2013 Q3	$156K	Sell	9,403 -16	-0.2%	-$237	﹤0.01%	2839
2013 Q2	$95K	Buy	+9,419	New	+$99K	﹤0.01%	2754

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Russell Frank Company's OSIR Position: Q1 2016 in Review

Russell Frank Company opened a new position in Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016: 11,800 shares worth $67K. The stake represents ﹤0.01% of the portfolio and ranks #2832 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in OSIR as recently as Q3 2015.

Russell Frank Company first reported a position in OSIR in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.19M in Q3 2015. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

Russell Frank Company held 11,800 shares of Osiris Therapeutics, Inc. Common Stock worth $67K as of Q1 2016.
Osiris Therapeutics, Inc. Common Stock was a new Russell Frank Company position in Q1 2016.
Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2832 holding.
Russell Frank Company first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
Russell Frank Company's Osiris Therapeutics, Inc. Common Stock position peaked at $2.19M in Q3 2015.
80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.